Treatment of unilateral olfactory neuroblastoma : Appropriate extent of surgical resection and potential for olfactory preservation
© 2024 ARS‐AAOA, LLC..
Historically, comprehensive surgical resection for olfactory neuroblastoma has included the bilateral olfactory epithelium, cribriform plate, overlying dura, olfactory bulbs and tracts. This results in postoperative anosmia that may significantly impact a patient's quality of life without definitive added benefit in survival. The prevalence of occult intracranial disease is low, especially for Hyams grade I and II tumors. A unilateral approach sparing the contralateral cribriform plate and olfactory system can be considered for select cases of early stage, low-grade tumors when the disease does not cross midline to involve the contralateral olfactory cleft or septal mucosa and when midline dural margins can be cleared with frozen pathology. Approximately half of patients who undergo unilateral resection may have residual olfaction even with adjuvant unilateral radiation. Early data suggest favorable disease-free survival and overall survival for patients who underwent the unilateral approach; however, larger sample studies are needed to confirm comparability to bilateral resections regarding oncologic outcomes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
International forum of allergy & rhinology - 14(2024), 5 vom: 09. Apr., Seite 881-886 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dharmarajan, Harish [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Esthesioneuroblastoma |
|---|
| Anmerkungen: |
Date Completed 25.04.2024 Date Revised 25.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/alr.23345 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370164768 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370164768 | ||
| 003 | DE-627 | ||
| 005 | 20240425233305.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240327s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/alr.23345 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1386.xml |
| 035 | |a (DE-627)NLM370164768 | ||
| 035 | |a (NLM)38526915 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dharmarajan, Harish |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment of unilateral olfactory neuroblastoma |b Appropriate extent of surgical resection and potential for olfactory preservation |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.04.2024 | ||
| 500 | |a Date Revised 25.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 ARS‐AAOA, LLC. | ||
| 520 | |a Historically, comprehensive surgical resection for olfactory neuroblastoma has included the bilateral olfactory epithelium, cribriform plate, overlying dura, olfactory bulbs and tracts. This results in postoperative anosmia that may significantly impact a patient's quality of life without definitive added benefit in survival. The prevalence of occult intracranial disease is low, especially for Hyams grade I and II tumors. A unilateral approach sparing the contralateral cribriform plate and olfactory system can be considered for select cases of early stage, low-grade tumors when the disease does not cross midline to involve the contralateral olfactory cleft or septal mucosa and when midline dural margins can be cleared with frozen pathology. Approximately half of patients who undergo unilateral resection may have residual olfaction even with adjuvant unilateral radiation. Early data suggest favorable disease-free survival and overall survival for patients who underwent the unilateral approach; however, larger sample studies are needed to confirm comparability to bilateral resections regarding oncologic outcomes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a esthesioneuroblastoma | |
| 650 | 4 | |a olfactory neuroblastoma | |
| 650 | 4 | |a olfactory preservation | |
| 650 | 4 | |a unilateral resection | |
| 700 | 1 | |a Choby, Garret |e verfasserin |4 aut | |
| 700 | 1 | |a Abi Hachem, Ralph |e verfasserin |4 aut | |
| 700 | 1 | |a Kuan, Edward C |e verfasserin |4 aut | |
| 700 | 1 | |a Levine, Corinna G |e verfasserin |4 aut | |
| 700 | 1 | |a Sanusi, Olabisi |e verfasserin |4 aut | |
| 700 | 1 | |a Schuman, Theodore |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Dennis |e verfasserin |4 aut | |
| 700 | 1 | |a Yim, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Geltzeiler, Mathew |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International forum of allergy & rhinology |d 2011 |g 14(2024), 5 vom: 09. Apr., Seite 881-886 |w (DE-627)NLM209105178 |x 2042-6984 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2024 |g number:5 |g day:09 |g month:04 |g pages:881-886 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/alr.23345 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2024 |e 5 |b 09 |c 04 |h 881-886 | ||